双氢青蒿素
谷胱甘肽
金属硫蛋白
下调和上调
GPX4
抗氧化剂
髓系白血病
化学
造血
新陈代谢
程序性细胞死亡
细胞生物学
药理学
癌症研究
青蒿素
生物化学
生物
细胞凋亡
免疫学
干细胞
恶性疟原虫
基因
谷胱甘肽过氧化物酶
酶
疟疾
作者
Éric Grignano,Lilia Cantero-Aguilar,Zubaidan Tuerdi,Thella Chabane,Romain Vazquez,Natacha Johnson,Jérémie Zerbit,Justine Decroocq,Rudy Birsen,Michaëla Fontenay,Olivier Kosmider,Nicolas Chapuis,Didier Bouscary
标识
DOI:10.1038/s41420-023-01371-8
摘要
Artemisinin is an anti-malarial drug that has shown anticancer properties. Recently, ferroptosis was reported to be induced by dihydroartemisinin (DHA) and linked to iron increase. In the current study, we determined the effect of DHA in leukemic cell lines on ferroptosis induction and iron metabolism and the cytoprotective effect triggered in leukemic cells. We found that treatment of DHA induces early ferroptosis by promoting ferritinophagy and subsequent iron increase. Furthermore, our study demonstrated that DHA activated zinc metabolism signaling, especially the upregulation of metallothionein (MT). Supportingly, we showed that inhibition MT2A and MT1M isoforms enhanced DHA-induced ferroptosis. Finally, we demonstrated that DHA-induced ferroptosis alters glutathione pool, which is highly dependent on MTs-driven antioxidant response. Taken together, our study indicated that DHA activates ferritinophagy and subsequent ferroptosis in AML and that MTs are involved in glutathione regenerating and antioxidant response.
科研通智能强力驱动
Strongly Powered by AbleSci AI